Black Diamond Therapeutics to Present at Investor Conferences

Monday, Mar 2, 2026 4:03 pm ET1min read
BDTX--

Black Diamond Therapeutics, a clinical-stage oncology company, will participate in the 46th Annual TD Cowen Healthcare Conference and the 25th Annual Needham Virtual Healthcare Conference. The company's President and CEO, Mark Velleca, and Chief Scientific Officer, Elizabeth Buck, will present at the conferences. The presentations will be webcast on the company's website and available for 90 days. Black Diamond is developing MasterKey therapies that target families of oncogenic mutations in patients with cancer.

Black Diamond Therapeutics to Present at Investor Conferences

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet